Safflower Extract Inhibits ADP-Induced Human Platelet Aggregation.

Area of Science:

• Pharmacology
• Traditional Chinese Medicine
• Biochemistry

Background:

• Safflower extract is a traditional Chinese medicine used to promote blood circulation and remove blood stasis.
• While its antioxidant and anticancer properties are known, its antiplatelet effects are less understood.

Purpose of the Study:

• To investigate the antiplatelet aggregation effects of safflower extract.
• To identify active components responsible for these effects and elucidate their mechanism of action.

Main Methods:

• Inhibition of human platelet aggregation induced by adenosine diphosphate (ADP).
• Analysis of active compounds including hydroxysafflor yellow A, safflower yellow A, and luteolin.
• Investigation of effects on ADP signaling pathways, including calcium ion and cAMP production.

Main Results:

• Safflower extract significantly inhibited ADP-induced human platelet aggregation.
• Hydroxysafflor yellow A, safflower yellow A, and luteolin demonstrated similar antiaggregative effects.
• Safflower extract modulated ADP receptor downstream signaling, affecting calcium and cAMP levels and glycoprotein expression.

Conclusions:

• Safflower extract possesses direct antiplatelet activation properties.
• The antiplatelet effects are mediated through the inhibition of ADP signaling pathways.
• These findings provide a scientific basis for the traditional use of safflower in managing circulatory disorders.